Sign in
Enrolling by invitationNo phase

Evaluation of a Twenty-session Cognitive-behavioral Therapy With Anorexia Nervosa (CBT-20-AN) Among Adults (18+)

Key facts

Who runs it
Massachusetts General Hospital
Where
Boston, United StatesSee the site
Trial code
Status
Enrolling by invitation
People taking part
40 people, planned
Started
22 Apr 2024
Expected to end
31 May 2029
Type of study
Interventional
Treatments tested
  • Twenty Session Cognitive-Behavioral Therapy for Anorexia Nervosa (CBT-20-AN)
Record updated
29 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 21 criteriaShow less

Who can take part

  • Eligible patients must meet DSM-5 criteria for anorexia nervosa. This diagnosis can be conferred via the EDE 17.0D
  • Age > 18
  • Patients must be able to provide informed consent and comply with the study procedures
  • Patients must be able to complete computer-based self-report questionnaires with adequate accommodation, if necessary
  • Patients must have a primary care physician, Adolescent Medicine physician, or consulting physician with eating disorder expertise at Massachusetts General Hospital/Massachusetts General Brigham network who can provide ongoing medical monitoring while the patient takes part in the study

Who cannot take part

  • Any condition that, after the baseline evaluation, is determined to preclude treatment with CBT
  • Concurrent psychotherapy. Patients must be willing to take a pause from any ongoing psychotherapy in order to focus on CBT-AN-20, which is in alignment with standard clinical care
  • Active untreated and unstable bipolar disorder (i.e. stable bipolar disorder under care of a psychiatrist is allowed)
  • Patients will be excluded if they exhibit:
  • BMI < 15, obtained via patient medical chart or from study 2023P000469 or 2018P002915
  • HR <55 or >100, obtained via patient medical chart or from study 2023P000469 or 2018P002915
  • Systolic BP (SBP and DBP) <80 or >160, obtained via patient medical chart or from study 2023P000469 or 2018P002915
  • Temperature < 96.5 F, obtained via patient medical chart or from study 2023P000469 or 2018P002915
  • Not eating food by mouth and/or any tube feeding, per EDE
  • Purging > 4x/week, per EDE
  • Active suicidality (suicidal ideation with intent or plan) to the point that more intensive treatment (i.e. acute hospitalization) is required
  • Psychosis
  • Intellectual disability
  • Symptoms that are not appropriate for outpatient level of care and therefore require a higher level of care (i.e. BMI <15 or purging more than 4x/week)
  • Homicidal ideation
  • Inability to speak English well enough to engage in CBT

Where in United States

  • Eating Disorders Clinical and Research ProgramBoston, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The study is a clinical trial assessing the efficacy of a new twenty session cognitive behavioral therapy for adults (18+) with anorexia nervosa (AN) and atypical anorexia nervosa. It is expected that participants will gain a significant amount of weight and experience a significant decrease in eating disorder psychopathology and behavior from pre- to post- treatment and that this will be retained after 6-months.

The group in the trial

  • CBT-20-ANTreatment being tested

    The single CBT-20-AN arm of this study is experimental, consisting of 20 weekly sessions and one-month, three-month, and six-month follow-ups.

    Treatment: Twenty Session Cognitive-Behavioral Therapy for Anorexia Nervosa (CBT-20-AN)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Twenty-session Cognitive-behavioral Therapy for Adults With Anorexia Nervosa (CBT-20-AN)
Record updated
29 July 2026